Consumer Group Urges FDA to Halt Study of Diabetes Drug Avandia
A national consumer advocacy group is urging the U.S. Food and Drug Administration (FDA) to end a safety study of the diabetes drug Avandia® begun in 2007, claiming the study puts patients at risk unnecessarily.